Invrix.com

Financial Statement Analysis Industry Analysis News Analysis

Login Register

Analysis Tools

Financial Trends Company Comparisons Profitability Radar Industry Leaderboard

User

Login Register

Home
/
Biotechnology: Biological Products (No Diagnostic Substances)
/
TSHA

Taysha Gene Therapies(Tsha) Financials: Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

Valuation Trend (Last 5 Years)

Top 20 by ratio

JSPR - Jasper Therapeutics
INTS - Intensity Therapeutics
CMPX - Compass Therapeutics
BNTX - BioNTech SE American Depositary Share
RLAY - Relay Therapeutics
KLTOW - Klotho Neurosciences
LXEO - Lexeo Therapeutics
MOLN - Molecular Partners AG
CGEN - Compugen Ltd.
WINT - Windtree Therapeutics
OCGN - Ocugen
RGNX - REGENXBIO
CRSP - CRISPR Therapeutics AG Common Shares
ATRA - Atara Biotherapeutics
VIR - Vir Biotechnology
MGX - Metagenomi
ATYR - aTyr Pharma
INAB - IN8bio
GNTA - Genenta Science S.
SNTI - Senti Biosciences

© 2025 Invrix. All rights reserved.

About Us Contact Privacy Policy Terms of Service